Collectively, the in-vitro and in-vivo results supported the hypothesis that overexpression of CTRP9 inhibits cellular and vascular senescence, thereby inhibiting the progression of atherosclerosis. This evidence concerns the gene C1QTNF9 and atherosclerosis.